You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 10, March 8, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Coffee Intake and Elevated Cholesterol and Apolipoprotein B Levels in Men

Paul T. Williams, MS; Peter D. Wood, DSc; Karen M. Vranizan, MA; John J. Albers, PhD; Susan C. Garay, MS; C. Barr Taylor, MD

JAMA. 1985;253(10):1407-1411.


Abstract

Coffee intake from three-day diet records was studied in association with plasma lipoprotein concentrations in a cross-sectional sample of 77 middle-aged American men to determine the significance and form of their interrelationships. The number of cups consumed per day correlated positively with levels of apolipoprotein B (r=.27, P≤.01) and became more strongly correlated when adjusted for age, cigarette use, adiposity, aerobic capacity, nutrient intake, and stress. Coffee intake also correlated with total cholesterol and low-density lipoprotein (LDL) cholesterol levels when adjusted for these confounding factors. Graphic analyses revealed that plasma concentrations of apolipoprotein B and LDL-cholesterol were unrelated to intake of up to 2 cups of coffee per day and positively associated with intake exceeding 2 to 3 cups. These results suggest that male heavy coffee drinkers have lipoprotein profiles suggestive of increased cardiovascular disease risk, although the causality remains to be determined.

(JAMA 1985;253:1407-1411)



Author Affiliations

From the Stanford Center for Research in Disease Prevention, Stanford University School of Medicine, Stanford, Calif (Mr Williams, Drs Wood and Taylor, and Mss Vranizan and Garay); and the Department of Medicine, University of Washington, Harborview Medical Center, Seattle (Dr Albers).


Footnotes

Reprint requests to Stanford Center for Research in Disease Prevention, 730 Welch Rd, Suite B, Stanford, CA 94305 (Mr Williams).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Coffee Consumption a Contributor to Cardiovascular Disease? Insights From the Framingham Study
Wilson et al.
Arch Intern Med 1989;149:1169-1172.
ABSTRACT  

The Tromso Heart Study: Family Approach to Intervention on CHD : sFeasibility of Risk Factor Reduction in High-risk Persons--Project Descriptions
Knutsen and Knutsen
Scand J Public Health 1989;17:109-119.
ABSTRACT  

High-Density Lipoprotein Cholesterol Measurements: A Help or Hindrance in Practical Clinical Medicine?
Superko et al.
JAMA 1986;256:2714-2717.
ABSTRACT  

Coffee Intake and Serum Lipids in Men
Weyrauch
JAMA 1985;254:2737-2737.
ABSTRACT  

Coffee Intake and Serum Lipids in Men
Hershberg
JAMA 1985;254:2737-2738.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.